Johnson & Johnson (JNJ) vs AstraZeneca (AZN)
Johnson & Johnson (JNJ) and AstraZeneca (AZN) side by side: both in Healthcare, listed on New York Stock Exchange and London Stock Exchange. Johnson & Johnson is the larger of the two by approximate market capitalization (about 2.6×).
| Field | Johnson & Johnson | AstraZeneca |
|---|---|---|
| Legal name | Johnson & Johnson | AstraZeneca PLC |
| Ticker | JNJ | AZN |
| Exchange | New York Stock Exchange XNYS | London Stock Exchange XLON |
| Jurisdiction | United States | United Kingdom |
| Sector | Healthcare | Healthcare |
| Industry | Pharma & MedTech | Pharmaceuticals |
| Market cap ≈ | $645.9bn | $252.2bn |
| Founded | 1886 | 1999 |
| Reporting currency | USD | GBP |
| LEI | 549300G0CFPGEF6X2043 | PY6ZZQWO2IZFZC3IOL08 |
| ISIN | US4781601046 | GB0009895292 |
| FIGI | BBG001S5SHQ9 | BBG001SCNW31 |
| Index membership | S&P 500 | FTSE 100 |
| Held by (covered funds) | — | — |
AstraZeneca
Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.
Market caps are computed from each issuer's own filed share count times the close on 2026-08-28, not copied from a vendor; LEI from GLEIF (CC0), ISIN read from each issuer's own primary listing document with its ISO 6166 check digit validated, FIGI from OpenFIGI, MIC from the ISO 10383 registry — full provenance on Sources. Not real-time, not investment advice. Both sides as data: /api/v1/companies/johnson-johnson · /api/v1/companies/astrazeneca